ID CBLBA_XENLA Reviewed; 918 AA. AC Q6GQL0; DT 07-FEB-2006, integrated into UniProtKB/Swiss-Prot. DT 19-JUL-2004, sequence version 1. DT 02-SEP-2026, entry version 111. DE RecName: Full=E3 ubiquitin-protein ligase CBL-B-A; DE EC=2.3.2.27 {ECO:0000250|UniProtKB:Q13191}; DE AltName: Full=RING-type E3 ubiquitin transferase CBL-B-A {ECO:0000305}; DE AltName: Full=SH3-binding protein CBL-B-A; DE AltName: Full=Signal transduction protein CBL-B-A; GN Name=cblb-a; OS Xenopus laevis (African clawed frog). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia; OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus. OX NCBI_TaxID=8355; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Spleen; RG NIH - Xenopus Gene Collection (XGC) project; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from CC specific E2 ubiquitin-conjugating enzymes, and transfers it to CC substrates, generally promoting their degradation by the proteasome. CC {ECO:0000250|UniProtKB:Q13191}. CC -!- CATALYTIC ACTIVITY: CC Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + CC [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L- CC cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; CC EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q13191}; CC -!- PATHWAY: Protein modification; protein ubiquitination. CC -!- SUBUNIT: Interacts with several SH3 domain-containing proteins and with CC poly-ubiquitinated proteins. {ECO:0000250|UniProtKB:Q13191}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13191}. CC -!- DOMAIN: The N-terminus is composed of the phosphotyrosine binding (PTB) CC domain, a short linker region and the RING-type zinc finger. The PTB CC domain, which is also called TKB (tyrosine kinase binding) domain, is CC composed of three different subdomains: a four-helix bundle (4H), a CC calcium-binding EF hand and a divergent SH2 domain. CC -!- DOMAIN: The RING-type zinc finger domain mediates binding to an E2 CC ubiquitin-conjugating enzyme. {ECO:0000250|UniProtKB:Q13191}. CC -!- MISCELLANEOUS: This protein has one functional calcium-binding site. CC {ECO:0000250}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC072732; AAH72732.1; -; mRNA. DR RefSeq; NP_001085428.1; NM_001091959.1. DR AlphaFoldDB; Q6GQL0; -. DR SMR; Q6GQL0; -. DR DNASU; 443854; -. DR GeneID; 443854; -. DR KEGG; xla:443854; -. DR AGR; Xenbase:XB-GENE-6251733; -. DR CTD; 443854; -. DR Xenbase; XB-GENE-6251733; cblb.L. DR OrthoDB; 7237699at2759; -. DR UniPathway; UPA00143; -. DR Proteomes; UP000186698; Chromosome 2L. DR Bgee; 443854; Expressed in testis and 19 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0045121; C:membrane raft; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0001784; F:phosphotyrosine residue binding; IEA:InterPro. DR GO; GO:0030971; F:receptor tyrosine kinase binding; IBA:GO_Central. DR GO; GO:0017124; F:SH3 domain binding; IEA:TreeGrafter. DR GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB. DR GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro. DR GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IBA:GO_Central. DR GO; GO:0050868; P:negative regulation of T cell activation; ISS:UniProtKB. DR GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB. DR GO; GO:0050821; P:protein stabilization; ISS:UniProtKB. DR GO; GO:2000583; P:regulation of platelet-derived growth factor receptor-alpha signaling pathway; ISS:UniProtKB. DR GO; GO:0007165; P:signal transduction; IBA:GO_Central. DR CDD; cd16708; RING-HC_Cbl; 1. DR CDD; cd09920; SH2_Cbl-b_TKB; 1. DR FunFam; 1.10.238.10:FF:000022; E3 ubiquitin-protein ligase CBL; 1. DR FunFam; 1.20.930.20:FF:000001; E3 ubiquitin-protein ligase CBL; 1. DR FunFam; 3.30.40.10:FF:000015; E3 ubiquitin-protein ligase CBL; 1. DR FunFam; 3.30.505.10:FF:000154; E3 ubiquitin-protein ligase CBL; 1. DR Gene3D; 1.20.930.20; Adaptor protein Cbl, N-terminal domain; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR Gene3D; 3.30.505.10; SH2 domain; 1. DR Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1. DR InterPro; IPR024162; Adaptor_Cbl. DR InterPro; IPR014741; Adaptor_Cbl_EF_hand-like. DR InterPro; IPR036537; Adaptor_Cbl_N_dom_sf. DR InterPro; IPR003153; Adaptor_Cbl_N_hlx. DR InterPro; IPR014742; Adaptor_Cbl_SH2-like. DR InterPro; IPR024159; Cbl_PTB. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR036860; SH2_dom_sf. DR InterPro; IPR018957; Znf_C3HC4_RING-type. DR InterPro; IPR001841; Znf_RING. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR InterPro; IPR017907; Znf_RING_CS. DR PANTHER; PTHR23007; CBL; 1. DR PANTHER; PTHR23007:SF3; E3 UBIQUITIN-PROTEIN LIGASE CBL-B; 1. DR Pfam; PF02262; Cbl_N; 1. DR Pfam; PF02761; Cbl_N2; 1. DR Pfam; PF02762; Cbl_N3; 1. DR Pfam; PF00097; zf-C3HC4; 1. DR SMART; SM00184; RING; 1. DR SUPFAM; SSF47473; EF-hand; 1. DR SUPFAM; SSF47668; N-terminal domain of cbl (N-cbl); 1. DR SUPFAM; SSF57850; RING/U-box; 1. DR SUPFAM; SSF55550; SH2 domain; 1. DR PROSITE; PS51506; CBL_PTB; 1. DR PROSITE; PS00518; ZF_RING_1; 1. DR PROSITE; PS50089; ZF_RING_2; 1. PE 2: Evidence at transcript level; KW Calcium; Cytoplasm; Immunity; Metal-binding; Reference proteome; Repeat; KW Transferase; Ubl conjugation pathway; Zinc; Zinc-finger. FT CHAIN 1..918 FT /note="E3 ubiquitin-protein ligase CBL-B-A" FT /id="PRO_0000055863" FT DOMAIN 46..354 FT /note="Cbl-PTB" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00839" FT ZN_FING 384..423 FT /note="RING-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00175" FT REGION 1..27 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 46..178 FT /note="4H" FT REGION 179..251 FT /note="EF-hand-like" FT REGION 252..354 FT /note="SH2-like" FT REGION 355..383 FT /note="Linker" FT REGION 481..582 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 780..831 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 857..918 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1..18 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 483..497 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 554..576 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 821..830 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 898..918 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 232 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P22681" FT BINDING 234 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P22681" FT BINDING 236 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P22681" FT BINDING 238 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P22681" FT BINDING 243 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:P22681" FT BINDING 297 FT /ligand="4-O-phospho-L-tyrosine" FT /ligand_id="ChEBI:CHEBI:62338" FT /evidence="ECO:0000250" SQ SEQUENCE 918 AA; 102831 MW; 5CEB1FDCBCE9D572 CRC64; MASGSGSSSS TSSSALSGRL PGSRSANPRK ARILGLFDAI QDAVGPPKQA AADRRTVEKT WKLMDKVVRL CQNPKLQLKN SPPYILDILP DTYQHLRLIL SKYDDNQKLA QLSENEYFKI YIDSLIKKSK RAMRLFKEGK ERMYEEQSQE RRNLTKLSLI FSHMLAEIKA IFPSGQFQGD NFRITKADAA EFWRKFFGER TIVPWKIFRQ CLHEVHQISS GLEAMALKST IDLTCNDYIS VFEFDIFTRL FQPWGSILRN WNFLAVTHPG YMAFLTYDEV KARLQKYSLK PGSYIFRLSC TRLGQWAIGY VTADGNILQT IPHNKPLFQA LIDGSREGFY LYPDGRSYNP DLTGLCEPTP HDHIKVTQEQ YELYCEMGST FQLCKICAEN DKDVKIEPCG HLMCTSCLTS WQESDGQGCP FCRCEIKGME PIIVDPFDPR DESRCFSFSD SLCTPMLDFD DDDLREECLI MNRLAALRKM NERQNSPVTS PGSSPLSQRR KTPPEPLQIP HLNLPPVPPR LDLIQKGLAR SPCASPTGSP KSSPCMVRKQ DKPLPAPPPL LREPPPPPER PPPIPPDSRT CRHLHHADNV PCRDQSTPHE AWCTRDLSGG NPASVCRVTH DGSPKLGVPS SSVLNGRHSR MSTEAGFMRH KHHKRRESPL ETLRVYNGLS GNEEYDVPPR LSPPTITIHP IVKCPVLVNS VSDKVRNSAE EDDCEYKIPS SHPVSSRLPL HCHSIKHFPR LCENGQCLSN GTHNGISEIK KLKPPDQGDV IATSTVPIHF PPARTSAREN HPHGSSLTRT PSDYDLLVPH PGEESFDISP PSQPPPPPPA RTCVTEHVMP TALGSRPNSD VDLFLPHSDP CPEAPLPPAR RGPGEVKSNR LSQEYDQLPS CPGKGQEKAS NTKGELLLPN QNLIMRPT //